메뉴 건너뛰기




Volumn 29, Issue 2, 1990, Pages 155-162

Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma: A randomized trial

Author keywords

Advanced; Adverse effects; Anbibodies; Interferon; Liver enzymes; Medroxyprogesterone; Random allocation; Renal adenocarcinoma

Indexed keywords

ALPHA2A INTERFERON; AMINOTRANSFERASE; MEDROXYPROGESTERONE ACETATE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT INTERFERON;

EID: 0025247712     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869009126537     Document Type: Article
Times cited : (80)

References (14)
  • 6
    • 0023296168 scopus 로고
    • Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a intramuscular injection
    • (1987) Cancer , vol.59 , pp. 668-674
    • Itri, L.M.1    Campion, M.2    Dennin, R.A.3
  • 9
    • 0022455717 scopus 로고
    • Phase II study of alpha interferon on renal cell carcinoma: Summary of three collaborative trials
    • (1986) Cancer , vol.58 , pp. 1231-1235
    • Umeda, T.1    Niijima, T.2
  • 12
    • 0023296171 scopus 로고
    • Interferon treatment of renal cell carcinoma: Current status and future prospects
    • (1987) Cancer , vol.59 , pp. 647-651
    • Krown, S.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.